Verve Therapeutics is a biotechnology company focused on discovering and developing therapies that safely edit the genomes of adults to confer lifelong protection against coronary artery disease, the most common type of heart disease and the leading cause of death worldwide.

Biotechnology

Education

Verve Therapeutics

Verve Therapeutics' headquarters in Cambridge, MA, United States

Sekar Kathiresan

Oscar Velazquez Cuazitl

Payal Pranami

Victor Farutin

Ivan Ivanov

Estela Shabani

Michael Bergin

Mrinal Kumar

Associate Director, Medical Affairs And Scientific Communications

Director, Human Resources Business Partner

Abigail Eisner

Joe Biedenkapp

Yasser El-Gamal

Leslie Stolz

Kallanthottathil G. Rajeev

J. Keith Joung

Peixin Zhu

Richard Falzone

Amit Khera

Issi Rozen

Anthony Philippakis

Sheila Mikhail

Penny M. Heaton

Andrew Geall

Krishna Yeshwant

Eugene Braunwald

Kiran Musunuru

Burt Adelman

Daniel J. Rader

This department specializes in the research and development of editing techniques and processes to enhance product efficacy.

Editing and Discovery

The Regulatory Affairs and Compliance team at Verve Therapeutics is responsible for ensuring that all therapeutic developments comply with regulatory standards and guidelines. They oversee the preparation and submission of regulatory documents, facilitate communication with regulatory agencies, and ensure adherence to quality assurance protocols throughout the product lifecycle. This team plays a crucial role in navigating the complex regulatory landscape to bring innovative genomic therapies to market safely and effectively.

Regulatory Affairs and Compliance

The Research and Development team at Verve Therapeutics is dedicated to pioneering innovative genomic editing therapies aimed at providing lasting protection against coronary artery disease. Comprised of skilled scientists and associates specializing in areas such as bioanalysis, pharmacology, and computational biology, the team collaborates to discover and optimize novel therapeutic approaches while rigorously evaluating their safety and efficacy across preclinical and clinical stages of development.

Research and Development

The Quality Control and Assurance team at Verve Therapeutics is dedicated to ensuring that all therapeutic products meet rigorous safety and efficacy standards. This team conducts assessments and audits, oversees stability testing, and ensures compliance with regulatory requirements, thereby safeguarding the integrity of the company's innovative genomic editing therapies. Their collaborative efforts are vital in maintaining high-quality manufacturing processes and protecting patient safety.

Quality Control and Assurance

This department oversees the planning, execution, and management of clinical operations and regulatory strategies for medical affairs.

Clinical Operations and Strategy

This department conducts research and development activities focused on pharmacological assessments before clinical trials.

Preclinical Pharmacology

Verve Therapeutics

Org chart

Board & advisors

Teams

Editing and Discovery

Regulatory Affairs and Compliance

Research and Development

Quality Control and Assurance

Clinical Operations and Strategy

Preclinical Pharmacology

Offices

Verve Therapeutics

Org chart

Board & advisors

Teams

Editing and Discovery

Regulatory Affairs and Compliance

Research and Development

Quality Control and Assurance

Clinical Operations and Strategy

Preclinical Pharmacology

Offices

Related companies